-
1 Comment
Kubota Pharmaceutical Holdings Co., Ltd is currently in a long term downtrend where the price is trading 9.3% below its 200 day moving average.
From a valuation standpoint, the stock is 351.8% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 318.6.
Kubota Pharmaceutical Holdings Co., Ltd's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has increased by 30.0% to $-566M since the same quarter in the previous year.
Finally, its free cash flow grew by 30.1% to $-511M since the same quarter in the previous year.
Based on the above factors, Kubota Pharmaceutical Holdings Co., Ltd gets an overall score of 2/5.
| Exchange | TSE |
|---|---|
| CurrencyCode | JPY |
| Sector | Healthcare |
| Industry | Biotechnology |
| ISIN | JP3266500002 |
| PE Ratio | None |
|---|---|
| Dividend Yield | None |
| Beta | 1.94 |
| Market Cap | 11B |
Kubota Pharmaceutical Holdings Co., Ltd. engages in the pharmaceutical and medical device business worldwide. The company offers eyeMO, a remote retinal monitoring device for home-based and patient self-monitoring optical coherence tomography; and a NASA high-res version OCT device. It also provides Emixustat HCI compounds for Stargardt disease indications in Phase 3 clinical trials, as well as proliferative diabetic retinopathy and diabetic macular edema in Phase 2 clinical trials. The company was founded in 2002 and is headquartered in Minato, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4596.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026